Sort
39,280 grants matching “leukemia”
Pharmacogenetic Determinants of Vincristine Toxicity and Response
$614,577Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2016 · HD
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.
$614,564Kimberly Pauline Raghubar · Baylor College Of Medicine · R01 · FY2023 · CA
Gene Regulation By Steroid Receptor Proteins
$614,558Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2015 · CA
Gene Regulation By Steroid Receptor Proteins
$614,558Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2016 · CA
Pediatric Clinical Oncology Research Training Program
$614,521David G. Poplack · Baylor College Of Medicine · K12 · FY2010 · CA
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$614,372Verena Staedtke · Johns Hopkins University · U01 · FY2022 · CA
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$614,362Verena Staedtke · Johns Hopkins University · U01 · FY2021 · CA
Clinical Transplantation Exploiting NK Cell Activity
$614,359Daniel J Weisdorf · University Of Minnesota · P01 · FY2007 · CA
Lentiviral Gene Therapy and Genome Editing for Wiskott-Aldrich Syndrome
$614,320David J Rawlings · St. Jude Children'S Research Hospital · P01 · FY2020 · HL
Multi-wavelength femtosecond laser sources for intravital multiphoton microscopy
$614,300Chris Xu · Cornell University · R01 · FY2016 · EB
Structural insights into the MLL core complexes
$614,292Yali Dou · University Of Southern California · R01 · FY2020 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$614,259Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Optimization of gene transfer safety and efficacy focusing on the NHP model
$614,238Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
$614,214Todd A Fehniger · Washington University · R01 · FY2017 · CA
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
$614,214Todd A Fehniger · Washington University · R01 · FY2020 · CA
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
$614,214Todd A Fehniger · Washington University · R01 · FY2018 · CA
Roles of Endogenous Retroviruses in Cancer and Auto-immune Diseases
$614,121Leonard Evans · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
The developmental pathway of fetal-derived B cells
$614,077Momoko Yoshimoto · Western Michigan Univ School Of Medicine · R01 · FY2025 · AI
Targeting LIF/LIFR in pancreatic cancer
$614,006Hareesh Babu Nair · Evestra, Inc. · R44 · FY2020 · CA
Exercise and QUality diet After Leukemia
$613,996Emily Smith Tonorezos · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Analysis of E-selectin Ligands of Human Acute Leukemia Cells and their Biology in Leukemogenesis
$613,888Robert Sackstein · Florida International University · U01 · FY2020 · CA
Adrenergic modulation of cellular immune functions in CAR T cell-induced cytokine release syndrome
$613,864Verena Staedtke · Johns Hopkins University · U01 · FY2023 · CA
Role of lncRNA mediated R-loops in CTCF boundary function and AML genome organization
$613,836Suming Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · CA
ITIM-receptors for cancer treatment
$613,805Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2020 · CA
Project 3: Gene Therapy for Correction of Blood Disorders
$613,758Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2016 · HL